Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Emergence Agitation in Children
NCT03596775Phase 1Unknown
- Sponsor
- Xuzhou Medical University
- Start
- Sep 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Xuzhou Medical University. Primary endpoint: Incidence of Emergence Agitation at 30 minutes. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT03596775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596775.